BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7394957)

  • 1. Value of new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer.
    Lee CL; Chu TM; Wajsman LZ; Slack NH; Murphy GP
    Urology; 1980 Apr; 15(4):338-41. PubMed ID: 7394957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 3. Solid-phase immunofluorescent and immunoadsorbent assays of serum prostatic acid phosphatase.
    Lee CL; Wang MC; Killian CS; Slack NH; Murphy GP; Chu TM
    Prostate; 1980; 1(4):427-39. PubMed ID: 6792613
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
    Bauer HW; Schmeller NT
    Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic acid phosphatase.
    Ablin RJ
    Lancet; 1979 May; 1(8126):1145-6. PubMed ID: 86868
    [No Abstract]   [Full Text] [Related]  

  • 6. A solid-phase immunoadsorbent assay for serum prostatic acid phosphatase.
    Lee CL; Killian CS; Murphy GP; Chu TM
    Clin Chim Acta; 1980 Feb; 101(2-3):209-16. PubMed ID: 7357745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostatic acid phosphatase measured by amplified enzyme linked immunoassay. Its application to mass screening for prostatic tumor and monitoring the clinical course of prostatic cancer patients].
    Yamanaka H; Yuasa H; Natori E; Imai K; Mashimo T
    Rinsho Byori; 1987 Oct; 35(10):1154-8. PubMed ID: 3325662
    [No Abstract]   [Full Text] [Related]  

  • 8. The evaluation of a new enzyme immunoassay for the measurement of prostatic acid phosphatase.
    Cooper EH; Glashan R; Robinson MR; Morgan DB; Trautner K
    Clin Chim Acta; 1981 Jun; 113(1):27-34. PubMed ID: 6165505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A solid-phase fluorescent immunoassay for human prostatic acid phosphatase.
    Lee CI; Wang MC; Murphy GP; Chu TM
    Cancer Res; 1978 Sep; 38(9):2871-8. PubMed ID: 354781
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostatic acid phosphatase: its current clinical status.
    Heller JE
    J Urol; 1987 Jun; 137(6):1091-103. PubMed ID: 3295298
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
    Sakai H; Shiraishi K; Minami Y; Yushita Y; Kanetake H; Saito Y
    Prostate; 1991; 19(3):265-72. PubMed ID: 1946042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme immunoassay for the prostate-specific acid phosphatase (E. C. 3.1.3.2).
    Bauer HW; Göttinger H; Grenner G; Dati F
    Urol Res; 1981; 9(1):21-4. PubMed ID: 7022994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A solid-phase radioimmunoassay for human prostatic acid phosphatase.
    Foti AG; Herschman H; Cooper JF
    Cancer Res; 1975 Sep; 35(9):2446-52. PubMed ID: 1170944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic and clinical studies of radioimmunoassay kit for prostatic acid phosphatase (author's transl)].
    Maruoka M; Suzuki S; Sato K; Nozumi K; Yasuda K; Ito H; Shimazaki J
    Kaku Igaku; 1981 Dec; 18(10):1523-9. PubMed ID: 7341812
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
    Oesterling JE; Brendler CB; Epstein JI; Kimball AW; Walsh PC
    J Urol; 1987 Jul; 138(1):92-8. PubMed ID: 3599229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic detection of prostatic acid phosphatase: critique I.
    Romas NA; Tannenbaum M
    Hum Pathol; 1978 Nov; 9(6):620-1. PubMed ID: 730145
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunohistochemical study on prostatic acid phosphatase].
    Yoshida M; Miki M
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):514-22. PubMed ID: 6353022
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation and measurement of plasma prostatic acid phosphatase by solid phase enzyme immunoassay].
    Okabe H; Noma A; Nakauchi K; Mori M
    Rinsho Byori; 1986 Jul; 34(7):805-10. PubMed ID: 2428995
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostatic acid phosphatase: current concepts.
    Romas NA
    Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.